Drugs & Targets FDA Approves Gilotrif Tablets for Squamous Cell Lung Cancer April 25, 2016Vol.42 No.16
Drugs & Targets University of Chicago and AbbVie to form five-year collaboration April 25, 2016Vol.42 No.16
Cell Therapy Production, Patient Accrual Suspended at Rosenberg’s Lab at NCI April 25, 2016Vol.42 No.16By Paul Goldberg
BSA Approves Plan to Expand SEER Infrastructure, Funding, and Research Support Capacity April 25, 2016Vol.42 No.16By Conor Hale
In Brief Nancy Davidson Begins Term as AACR President; Weinberg Receives Lifetime Achievement Award April 25, 2016Vol.42 No.16
Comparison with AstraZeneca Drug Hard to Ignore as ODAC Votes Down NSCLC Application from Clovis April 25, 2016Vol.42 No.16By Paul Goldberg
In Brief International Myeloma Foundation to fund large screening study in Iceland April 18, 2016Vol.42 No.15
Drugs & Targets FDA Grants Accelerated Approval to Venclexta Tablets in CLL April 18, 2016Vol.42 No.15
